Nov 14, 2016 7:00 am EST Heat Biologics Presents ComPACT Preclinical Data at the Society for Immunotherapy of Cancer Annual Meeting
Nov 10, 2016 4:47 pm EST Heat Biologics Provides Corporate Update and Reports Third Quarter 2016 Financial Results
Nov 07, 2016 7:00 am EST Heat Biologics to Present at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Oct 17, 2016 7:30 am EDT Heat Biologics to Present at Two Upcoming Investor Conferences and Panel Discussion
Oct 13, 2016 7:00 am EDT Heat Biologics Remains on Track to Achieve Multiple Topline Data Readouts this Quarter
Oct 11, 2016 7:30 am EDT Heat Biologics Selects Adaptive Biotechnologies to Discover Potential Clinical Biomarkers to Advance Novel Immunotherapies
Oct 07, 2016 7:00 am EDT Heat Biologics Substantially Reduces Debt and Reports Proceeds of Approximately $2.8 Million Year-to-Date from the Exercise of Warrants
Sep 14, 2016 7:00 am EDT Heat Biologics Resumes Enrollment in its Non-Small Cell Lung Cancer Trial Evaluating HS-110 in Combination with Anti-PD-1 Checkpoint Inhibitor